Literature DB >> 27492003

Draft Genome Sequence of Lactococcus garvieae Strain PAQ102015-99, an Outbreak Strain Isolated from a Commercial Trout Farm in the Northwestern United States.

Michael C Nelson1, Jed S Varney2, Timothy J Welch3, Joerg Graf4.   

Abstract

We announce the draft genome assembly of Lactococcus garvieae strain PAQ102015-99, a recently isolated strain from an outbreak of lactococcosis at a commercial trout farm in the northwestern United States. The draft genome comprises 14 contigs totaling 2,068,357 bp with an N50 of 496,618 bp and average G+C content of 38%.
Copyright © 2016 Nelson et al.

Entities:  

Year:  2016        PMID: 27492003      PMCID: PMC4974324          DOI: 10.1128/genomeA.00781-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Lactococcus garvieae, the causative agent of lactococcosis, is a highly virulent Gram-positive pathogen of rainbow trout (Oncorhynchus mykiss) and is recognized as one of the most significant disease threats to the European trout farming industry (1, 2). Lactococcosis was originally identified in Italy and Spain but rapidly spread throughout most of Europe and the United Kingdom and subsequently has been documented in Australia and South Africa (3–5). L. garvieae has also been a major cause of loss in cultured marine fish in Asia (6) and strains of L. garvieae have been associated with disease in other animals, humans, and isolated from human food sources (7, 8). Recently, we identified an outbreak of lactococcosis at a rainbow trout farm in the Pacific Northwest region of the United States. Like European strains of L. garvieae, outbreak strains in the United States are highly virulent for rainbow trout and cause high mortality in infected stocks. Here, we report the draft genome sequence of a representative United States L. garvieae isolate (strain PAQ102015-99), which was isolated from the head kidney of a rainbow trout showing clinical signs of lactococcosis. Whole-genome shotgun sequencing was conducted using an Illumina MiSeq on a NexteraXT prepared library. Quality filtering, trimming, and de novo assembly were performed using CLC Genomics Workbench v8.5.1. Functional annotation was conducted with Prokka (9), using currently available L. garvieae genomes as the initial reference database for annotation. The draft genome consists of 14 contigs totaling 2,068,357 bp with an N50 value of 496,618 and average G+C content of 38.0%. A total of 1,947 predicted CDSs, 47 tRNAs, and 5 rRNAs were identified after annotation. Six hundred fourteen CDS features were identified as hypothetical proteins while 31 were identified as phage related. Important features related to pathogenicity and virulence included genes for colicins and related iron acquisition and metabolism, antibiotic resistance, cell adherence and invasion, and hyaluronic acid metabolism. Availability of this United States strain genome sequence will allow comparison to the genomes of European and Asia strains and thus provide a better understanding of the evolutionary relationship among these strains and insight into the emergence of this pathogen in the United States.

Accession number(s).

The raw sequencing and contig data are available from GenBank/ENA/DDBJ under BioProject accession number PRJNA320828. The annotated assembly is directly available under accession number LXWL00000000.
  9 in total

Review 1.  Lactococcus garvieae in fish: a review.

Authors:  Daniel Vendrell; José Luis Balcázar; Imanol Ruiz-Zarzuela; Ignacio de Blas; Olivia Gironés; José Luis Múzquiz
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2006-08-28       Impact factor: 2.268

2.  Prokka: rapid prokaryotic genome annotation.

Authors:  Torsten Seemann
Journal:  Bioinformatics       Date:  2014-03-18       Impact factor: 6.937

3.  Lactococcus garvieae and Streptococcus iniae infections in rainbow trout Oncorhynchus mykiss: similar, but different diseases.

Authors:  A Eldar; C Ghittino
Journal:  Dis Aquat Organ       Date:  1999-05-31       Impact factor: 1.802

4.  Biodiversity of Lactococcus garvieae strains isolated from fish in Europe, Asia, and Australia.

Authors:  A Eldar; M Goria; C Ghittino; A Zlotkin; H Bercovier
Journal:  Appl Environ Microbiol       Date:  1999-03       Impact factor: 4.792

5.  Clonality and diversity of the fish pathogen Lactococcus garvieae in Mediterranean countries.

Authors:  Marina Eyngor; Amir Zlotkin; Claudio Ghittino; Marino Prearo; Diane-Gaëlle Douet; Stefan Chilmonczyk; Avi Eldar
Journal:  Appl Environ Microbiol       Date:  2004-09       Impact factor: 4.792

6.  Susceptibility of selected freshwater fish species to a UK Lactococcus garvieae isolate.

Authors:  M Algöet; A E Bayley; E G Roberts; S W Feist; R W Wheeler; D W Verner-Jeffreys
Journal:  J Fish Dis       Date:  2009-06-04       Impact factor: 2.767

7.  Genetic analysis of human clinical isolates of Lactococcus garvieae: Relatedness with isolates from foods.

Authors:  Mercedes Reguera-Brito; Fátima Galán-Sánchez; M Mar Blanco; Manuel Rodríguez-Iglesias; Lucas Domínguez; José F Fernández-Garayzábal; Alicia Gibello
Journal:  Infect Genet Evol       Date:  2015-11-28       Impact factor: 3.342

8.  Complete genome sequence and comparative analysis of the fish pathogen Lactococcus garvieae.

Authors:  Hidetoshi Morita; Hidehiro Toh; Kenshiro Oshima; Mariko Yoshizaki; Michiko Kawanishi; Kohei Nakaya; Takehito Suzuki; Eiji Miyauchi; Yasuo Ishii; Soichi Tanabe; Masaru Murakami; Masahira Hattori
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

9.  Draft Genome Sequence of Human-Pathogenic Lactococcus garvieae LG-ilsanpaik-gs201105 That Caused Acute Acalculous Cholecystitis.

Authors:  Ji Hyung Kim; Do-Hyung Kang; Se Chang Park
Journal:  Genome Announc       Date:  2015-06-04
  9 in total
  1 in total

Review 1.  The Promise of Whole Genome Pathogen Sequencing for the Molecular Epidemiology of Emerging Aquaculture Pathogens.

Authors:  Sion C Bayliss; David W Verner-Jeffreys; Kerry L Bartie; David M Aanensen; Samuel K Sheppard; Alexandra Adams; Edward J Feil
Journal:  Front Microbiol       Date:  2017-02-03       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.